Literature DB >> 1530810

Selective cerebral perfusion during operation for aneurysms of the aortic arch: a reassessment.

T Kazui1, N Inoue, O Yamada, S Komatsu.   

Abstract

Thirty-two consecutive patients with thoracic aortic aneurysms who required aortic arch reconstruction were operated on with the aid of extracorporeal circulation and selective cerebral perfusion between January 1986 and August 1990. For selective cerebral perfusion, blood was infused into both the innominate and left common carotid arteries at a rate of 10 mL.kg-1.min-1 using a single roller pump separately from the systemic circulation. In 9 patients treated before March 1987, the operations were performed without open aortic anastomosis (group 1), whereas in 23 patients treated from March 1987 onward we used open aortic anastomosis (group 2). The extracorporeal circulation and cardiac arrest times were significantly longer in group 2, but there was no significant difference in the cerebral perfusion time. Early death occurred in 1 patient in group 1 and 2 in group 2. No serious cerebrospinal neurological complications occurred in either group, and there were similar rates of postoperative hepatic and renal dysfunction in both groups. The present data suggest that selective cerebral perfusion and open aortic anastomosis are useful methods for thoracic aortic aneurysm operation requiring complex repair of the aortic arch.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1530810     DOI: 10.1016/0003-4975(92)90767-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  33 in total

1.  Cerebral perfusion in aortic arch surgery: antegrade, retrograde, or both?

Authors:  Taek-Yeon Lee; Hazim J Safi; Anthony L Estrera
Journal:  Tex Heart Inst J       Date:  2011

2.  Acute kidney injury after composite valve-graft replacement for ascending aorta aneurysms.

Authors:  Giovanni Mariscalco; Francesco Nicolini; Antonio Scannapieco; Riccardo Gherli; Filiberto Serraino; Carmelo Dominici; Attilio Renzulli; Tiziano Gherli; Andrea Sala; Cesare Beghi
Journal:  Heart Vessels       Date:  2012-03-13       Impact factor: 2.037

3.  Analysis of early and long-term outcomes of acute type A aortic dissection according to the new international aortic arch surgery study group recommendations.

Authors:  Andrea Colli; Massimiliano Carrozzini; Marco Galuppo; Marina Comisso; Francesca Toto; Dario Gregori; Gino Gerosa
Journal:  Heart Vessels       Date:  2015-11-17       Impact factor: 2.037

4.  Cerebral protection in hemi-aortic arch surgery.

Authors:  Mohamad Bashir; Matthew Shaw; Michael Desmond; Manoj Kuduvalli; Mark Field; Aung Oo
Journal:  Ann Cardiothorac Surg       Date:  2013-03

Review 5.  "Open" approach to aortic arch aneurysm repair.

Authors:  Adil H Al Kindi; Nasser Al Kimyani; Tarek Alameddine; Qasim Al Abri; Baskaran Balan; Hilal Al Sabti
Journal:  J Saudi Heart Assoc       Date:  2014-03-14

6.  Retrograde replacement of the thoracic aorta.

Authors:  D A Cooley
Journal:  Tex Heart Inst J       Date:  1995

7.  Retrograde cerebral perfusion exceeding 120 minutes in aortic arch reconstruction: a report of two cases.

Authors:  S Yamamoto; S Sasaguri; T Fukuda; Y Hosoda
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

Review 8.  Open repair techniques in the aortic arch are still superior.

Authors:  Jean Bachet
Journal:  Ann Cardiothorac Surg       Date:  2018-05

9.  Total and subtotal aortic replacement for extensive aortic dissection in patients with or without Marfan's syndrome.

Authors:  Katsushi Yamashita; Teruhisa Kazui; Hitoshi Terada; Naoki Washiyama; Takayasu Suzuki; Kazuhiro Ohkura; Hirosato Doi; Yohei Okawa; Kazuchika Suzuki; Takemi Ono
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-08

10.  Unilateral antegrade selective cerebral perfusion in aortic surgery: clinical outcomes at different levels of hypothermia.

Authors:  Jae Hoon Lee; Cheol Hyun Chung; Joon Kyu Kang; Suk Jung Choo; Hyun Song; Jae Won Lee
Journal:  J Korean Med Sci       Date:  2009-09-23       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.